Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Diagnostics (Basel, Switzerland)|July 27, 2022
Episodic Memory in Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer's Disease Dementia (ADD): Using the "Doors and People" Tool to Differentiate between Early aMCI-Late aMCI-Mild ADD Diagnostic GroupsAthanasios Chatzikostopoulos, Despina Moraitou, Magdalini Tsolaki, et al.
Neuromuscular Disorders : NMD|February 4, 2022
Biomarkers of disease progression in adolescents and adults with 5q spinal muscular atrophy: a systematic review and meta-analysisMaria Gavriilaki, Maria Moschou, Vasileios Papaliagkas, et al.
Current Alzheimer Research|June 28, 2022
Primary Sjögren's Syndrome Presenting with Rapidly Progressive Dementia: A Case ReportKonstantinos Notas, Vasileios Papaliagkas, Martha Spilioti, et al.
Cureus|December 22, 2025
Stress Biomarkers in Young Adult University Students Before, During, and After the COVID-19 Pandemic: A Longitudinal Cohort StudyIoannis Chaniotakis, Aikaterini Anetaki, Constantine Anetakis, et al.
International Journal of Molecular Sciences|March 27, 2025
Rare Case with Pathogenic Variant in DHX16 Gene Causing Neuromuscular Disease and Oculomotor AnomaliesStefania Kalampokini, Dimitrios G Goulis, Georgia Pepe, et al.
Diagnostics (Basel, Switzerland)|September 28, 2023
Cognitive Impairment in MRI-Negative Epilepsy: Relationship between Neurophysiological and Neuropsychological MeasuresVasileios Papaliagkas, Chrysanthi Lokantidou-Argyraki, Panayiotis Patrikelis, et al.
Current Alzheimer Research|June 24, 2016
MCI Patients in Europe: Medication and Comorbidities. The DESCRIPA StudyMagda Tsolaki, Vasileios Papaliagkas, Giovanni Frisoni, et al.
Case Reports in Neurology|December 24, 2021
Intrathecal Administration of Nusinersen Using the Ommaya Reservoir in an Adult with 5q-Related Spinal Muscular Atrophy Type 1 and Severe Spinal DeformityVasileios Papaliagkas, Nikolaos Foroglou, Petros Toulios, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|May 7, 2018
The cortical excitability profile of patients with the G209A SNCA mutation versus patients with sporadic Parkinson's disease: A transcranial magnetic stimulation studyVasilios K Kimiskidis, Sotirios Papayiannopoulos, Kyriaki Sotirakoglou, et al.
Pharmaceuticals (Basel, Switzerland)|March 6, 2021
Α Multicenter Retrospective Study Evaluating Brivaracetam in the Treatment of Epilepsies in Clinical PracticeMaria Stefanatou, Eirini Vasileiadou Kapetanou, Vasilios K Kimiskidis, et al.
Pageof 6